PROTEON THERAPEUTICS INC Business Finance Contracts & Agreements
27 Contracts & Agreements
- Assignment Agreements (2 contracts)
- Investor Rights Agreements (2)
- Purchase Agreements (1)
- Registration Rights Agreements (4)
- Release Agreements (2)
- Stock Agreements (6)
- Subscription Agreements (3)
- Underwriting Agreements (4)
- Warrant Agreements (3)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on December 11, 2024)
- Underwriting Agreement, dated December 9, 2024, by and among the Company, TD Securities (USA) LLC, Cantor Fitzgerald & Co. and LifeSci Capital LLC (Filed With SEC on December 11, 2024)
- Registration Rights Agreement, dated April 5, 2024 (Filed With SEC on April 5, 2024)
- Form of Common Stock Purchase Warrant (Filed With SEC on April 5, 2024)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on April 5, 2024)
- Subscription Agreement, dated April 5, 2024 (Filed With SEC on April 5, 2024)
- Underwriting Agreement related to the Preferred Offering, dated September 22, 2020, among Protara Therapeutics, Inc., Cowen and Company, LLC and Guggenheim Securities, LLC (Filed With SEC on September 23, 2020)
- Underwriting Agreement related to the Common Offering, dated September 22, 2020, among Protara Therapeutics, Inc., Cowen and Company, LLC and Guggenheim Securities, LLC (Filed With SEC on September 23, 2020)
- Forms of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under ArTara Therapeutics, Inc. Inducement Plan (Filed With SEC on March 30, 2020)
- Form of Stock Option Grant Notice and Stock Option Agreement under ArTara Therapeutics, Inc. Inducement Plan (Filed With SEC on March 30, 2020)
- Subscription Agreement, dated September 23, 2019, by and among the Registrant and the institutional investors named therein, and the First Amendment to Subscription Agreement,... (Filed With SEC on January 10, 2020)
- Form of Common Stock Certificate (Filed With SEC on January 10, 2020)
- Registration Rights Agreement, dated September 23, 2019, by and among Proteon Therapeutics, Inc. and the institutional investors named therein (Filed With SEC on September 24, 2019)
- Subscription Agreement, dated September 23, 2019, by and among Proteon Therapeutics, Inc. and the institutional investors named therein (Filed With SEC on September 24, 2019)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 3, 2017)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 23, 2017)
- FIFTH AMENDED AND RESTATED INVESTORS’RIGHTS AGREEMENT (Filed With SEC on June 23, 2017)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 23, 2017)
- PROTEON THERAPEUTICS,INC. $40,000,000 cOMMON STOCK SALES AGREEMENT (Filed With SEC on November 12, 2015)
- PROTEON THERAPEUTICS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on October 7, 2014)
- UNDERWRITING AGREEMENT [Number of Firm Shares] Shares Proteon Therapeutics, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on October 7, 2014)
- ASSIGNMENT OF PATENT (Filed With SEC on September 16, 2014)
- ASSIGNMENT OF RIGHTS/LICENSE AGREEMENT NIH Sponsored Invention (Filed With SEC on September 16, 2014)
- Exhibit A Form of Release of Claims (Filed With SEC on September 16, 2014)
- Release of Claims (Filed With SEC on September 16, 2014)
- SERIES D PREFERRED STOCK PURCHASE AGREEMENT (Filed With SEC on September 16, 2014)
- FOURTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on September 16, 2014)
